<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02596789</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A00316-37</org_study_id>
    <nct_id>NCT02596789</nct_id>
  </id_info>
  <brief_title>Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device</brief_title>
  <acronym>RC-TMS</acronym>
  <official_title>Study of Cortical Excitability in Healthy Subjects With Transcranial Magnetic Stimulation (TMS) and a Neuronavigation Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has two main goals :&#xD;
&#xD;
        -  to investigate the impact of aging on cortical excitability (CE)&#xD;
&#xD;
        -  to investigate the impact of &quot;state dependency&quot; on CE, using a cognitive task and an&#xD;
           emotional one.&#xD;
&#xD;
      A Neuronavigation system of transcranial magnetic stimulation is used, and electromyographic&#xD;
      response are recorded.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitudes of Motor evoked Potentials (µV) for ICI and ICF.</measure>
    <time_frame>Participants will be followed for an expected average of one month</time_frame>
    <description>Motor Evoked Potential (MEP) from the first dorsal interosseous are register during the stimulations.&#xD;
Intracortical Inhibition (ICI) and Facilitation (ICF) are a paired-pulse TMS measure of cortical excitability. A short Interval interstimuli (2ms) leads to a cortical inhibition, which reflects the GABAergic neurotransmission; whereas a longer interval interstimuli leads to a cortical facilitation, which reflects glutamatergic neurotransmission.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Durations of Cortical Silent Period (ms)</measure>
    <time_frame>Participants will be followed for an expected average of one month</time_frame>
    <description>Cortical Silent Period (CSP) is a single-pulse TMS measure of cortical inhibition, stimulations are applied while subjects are exerting a muscular contraction of the thum-index pinch and lead to a muscular cancellation. Duration of this silence is measured.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>state dependency TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>TMS performed at rest and during a cognitive/emotional task</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMS &quot;Magpro®, Magventure Inc&quot; device</intervention_name>
    <arm_group_label>state dependency TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male or female&#xD;
&#xD;
          -  age 18-75&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
          -  normal physical examination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  less 18 or more 75 years of age&#xD;
&#xD;
          -  contra indication to TMS: epilepsia or seizures, metallic head devices, cardiac&#xD;
             pacemaker, pregnancy, jet lag or severe insomnia the night before&#xD;
&#xD;
          -  severe physical disease&#xD;
&#xD;
          -  treatment with psychotropic drugs&#xD;
&#xD;
          -  overt psychiatric disease&#xD;
&#xD;
          -  alcohol consumption before the examination&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry BOUGEROL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry &amp; Neurology - University Hospital Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>July 23, 2014</study_first_submitted>
  <study_first_submitted_qc>November 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2015</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

